Arkis Biosciences

Read more
Chad Seaver's photo - Co-Founder & CEO of Arkis Biosciences

Co-Founder & CEO

Chad Seaver

CEO Approval Rating

81/100

ARKIS BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Chad Seaver

Co-Founder & CEO

- -
3
$7.9M
$4M
View Profile
1

Charles Dinardo

President

99/100
2,000
- -
$2.1B
View Profile
2

Kai Trompeter

CEO

85/100
30
$20M
$10M
View Profile
3

Robert LaDuca

CEO

89/100
500
$350K
$110M
View Profile
4

Thomas Engstrom

CEO

65/100
30
- -
$6.5M
View Profile
5

Brian J. Straeb

President & CEO

- -
192
- -
$85M
View Profile
6

Colin Ward

General Manager

71/100
18,000
- -
$8.8B
View Profile
7

CEO

- -
900
- -
$200M
View Profile
8

Max Gisbert Kley

CEO

85/100
1,662
- -
$231.3M
View Profile
9

Peter Neidecker

Co-Founder

69/100
61
- -
$5M
View Profile
10

Marc R. Buntaine

CEO

85/100
250
$59.8M
$18M
View Profile

Missing a competitor? Contribute!

Aesculap, Inc. is perceived as one of Arkis Biosciences's biggest rivals. Aesculap, Inc. was founded in 1977 in Center Valley, Pennsylvania. Aesculap, Inc. is in the Health Care Equipment field. Aesculap, Inc. generates $2.1B more revenue than Arkis Biosciences.

Insightra Medical is Arkis Biosciences's #2 rival. Insightra Medical is a Private company that was founded in 2001 in Clarksville, Tennessee. Insightra Medical competes in the Health Care Equipment field. Compared to Arkis Biosciences, Insightra Medical has 27 more employees.

Duke Empirical is one of Arkis Biosciences's top competitors. Duke Empirical's headquarters is in Santa Cruz, California, and was founded in 2000. Like Arkis Biosciences, Duke Empirical also operates in the Health Care Equipment industry. Duke Empirical generates 2,750% of Arkis Biosciences's revenue.

Arkis Biosciences Acquisitions

No recent acquisitions found related to Arkis Biosciences

Arkis Biosciences Funding History

Since Arkis Biosciences was founded in 2013, it has participated in 2 rounds of funding. In total Arkis Biosciences has raised $7.9M. Arkis Biosciences' last funding round was on Jan 2018 for a total of $4.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2018
$4.5M
-
Series A
Jun 2016
$3.4M

Since Arkis Biosciences was founded in 2013, it has participated in 2 rounds of funding. In total Arkis Biosciences has raised $7.9M. Arkis Biosciences' last funding round was on Jan 2018 for a total of $4.5M

Arkis Biosciences Investments

No recent investments found related to Arkis Biosciences

Arkis Biosciences News

Arkis Biosciences Press Releases

Arkis Biosciences Videos

Social Media

Arkis Biosciences Headquarters

1 Momentum Way P O Box 9815

Knoxville, Tennessee37920

844-247-5383

Driving Directions »

Trending Companies

Arkis Biosciences Summary

ABOUT

Overview

Arkis Biosciences is a medical device company that provides surgical and catheter tools for the treatment of intracranial hypertension. Arkis Biosciences was founded in 2013. Arkis Biosciences' headquarters is located in Knoxville, Tennessee, USA 3792...

CEO

Arkis Biosciences's Co-Founder & CEO, Chad Seaver, currently has an approval rating of 81%. Arkis Biosciences's primary competitors are Aesculap, Inc., Insightra Medical & Duke Empirical.

Frequently Asked Questions about Arkis Biosciences

  1. When was Arkis Biosciences founded?

    Arkis Biosciences was founded in 2013
  2. Who is Arkis Biosciences's CEO?

    Arkis Biosciences's CEO is Chad Seaver
  3. How much revenue does Arkis Biosciences generate?

    Arkis Biosciences generates $4M in revenue
  4. How much funding does Arkis Biosciences have?

    Arkis Biosciences has historically raised $7.9M in funding
  1. Where is Arkis Biosciences's headquarters?

    Arkis Biosciences's headquarters is in Knoxville Tennessee, USA
  2. How many employees does Arkis Biosciences have?

    Arkis Biosciences has 3 employees
  3. What sector does Arkis Biosciences operate in?

    Arkis Biosciences is in Health Care Equipment
  4. Who are Arkis Biosciences's competitors?

    Arkis Biosciences's top competitors are Aesculap, Inc., Insightra Medical, Duke Empirical